NERV
Price
$1.46
Change
+$0.01 (+0.69%)
Updated
May 23, 03:46 PM (EDT)
Capitalization
10.14M
81 days until earnings call
RLFTY
Price
$3.88
Change
+$0.98 (+33.79%)
Updated
May 22 closing price
Capitalization
48.53M
Interact to see
Advertisement

NERV vs RLFTY

Header iconNERV vs RLFTY Comparison
Open Charts NERV vs RLFTYBanner chart's image
Minerva Neurosciences
Price$1.46
Change+$0.01 (+0.69%)
Volume$100
Capitalization10.14M
RELIEF THERAPEUTICS HLDG AG
Price$3.88
Change+$0.98 (+33.79%)
Volume$4.32K
Capitalization48.53M
NERV vs RLFTY Comparison Chart
Loading...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NERV vs. RLFTY commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NERV is a Hold and RLFTY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (NERV: $1.45 vs. RLFTY: $3.88)
Brand notoriety: NERV and RLFTY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NERV: 0% vs. RLFTY: 890%
Market capitalization -- NERV: $10.14M vs. RLFTY: $48.53M
NERV [@Biotechnology] is valued at $10.14M. RLFTY’s [@Biotechnology] market capitalization is $48.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NERV’s FA Score shows that 0 FA rating(s) are green whileRLFTY’s FA Score has 1 green FA rating(s).

  • NERV’s FA Score: 0 green, 5 red.
  • RLFTY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLFTY is a better buy in the long-term than NERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NERV’s TA Score shows that 2 TA indicator(s) are bullish.

  • NERV’s TA Score: 2 bullish, 2 bearish.

Price Growth

NERV (@Biotechnology) experienced а -6.75% price change this week, while RLFTY (@Biotechnology) price change was +48.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

NERV is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLFTY($48.5M) has a higher market cap than NERV($10.1M). RLFTY YTD gains are higher at: -20.816 vs. NERV (-34.732). NERV has higher annual earnings (EBITDA): 6.02M vs. RLFTY (-48.16M). NERV has more cash in the bank: 21.4M vs. RLFTY (10.7M). NERV has less debt than RLFTY: NERV (0) vs RLFTY (2.42M). RLFTY has higher revenues than NERV: RLFTY (8.59M) vs NERV (0).
NERVRLFTYNERV / RLFTY
Capitalization10.1M48.5M21%
EBITDA6.02M-48.16M-13%
Gain YTD-34.732-20.816167%
P/E Ratio1.77N/A-
Revenue08.59M-
Total Cash21.4M10.7M200%
Total Debt02.42M-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NERV
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
N/A
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 24 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 24 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
76%
Declines
ODDS (%)
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 24 days ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BRZU59.45N/A
N/A
Direxion Daily MSCI Brazil Bull 2X ETF
WBIL30.71N/A
N/A
WBI BullBear Quality 3000 ETF
NLR87.67N/A
N/A
VanEck Uranium & Nuclear ETF
JPME100.95N/A
N/A
JPMorgan Divers Ret US Mid Cp Eq ETF
JEPQ52.16N/A
N/A
JPMorgan Nasdaq Equity Premium Inc ETF

NERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with GPCR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
N/A
GPCR - NERV
37%
Loosely correlated
+2.07%
DNLI - NERV
36%
Loosely correlated
-0.22%
CVAC - NERV
36%
Loosely correlated
N/A
AKRO - NERV
34%
Loosely correlated
+1.28%
ANAB - NERV
33%
Poorly correlated
N/A
More

RLFTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTY has been loosely correlated with RLFTF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTY jumps, then RLFTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTY
1D Price
Change %
RLFTY100%
+33.79%
RLFTF - RLFTY
43%
Loosely correlated
+45.38%
ORKA - RLFTY
23%
Poorly correlated
+5.77%
PCVX - RLFTY
21%
Poorly correlated
-0.06%
HOTH - RLFTY
21%
Poorly correlated
+0.55%
NERV - RLFTY
21%
Poorly correlated
N/A
More